Stock A200670 HUMEDIX CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Humedix Co., Ltd.

Equities

A200670

KR7200670008

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-16 pm EDT 		5-day change 1st Jan Change
33,950 KRW +2.72% Intraday chart for Humedix Co., Ltd. +0.44% +0.59%
2023 Tranche Update on Humedix Co., Ltd.'s Equity Buyback Plan announced on September 27, 2022. CI
2023 Humedix Co., Ltd.'s Equity Buyback announced on September 27, 2022, has expired with 145,877 shares, representing 1.58% for KRW 2,992.33 million. CI

Business Summary

Humedix Co., Ltd. is a Korea-based company principally engaged in the manufacture and distribution of pharmaceuticals .The Company’s main products consist of preparations for the treatment of arthritis, prescription drugs, medicament for the eyes, active pharmaceutical ingredients (APIs), as well as cosmetics and others. The Company distributes its products within domestic market and to overseas markets

Number of employees: 248

Sales per Business

KRW in Million2022Weight2023Weight Delta
Hyaluronic Acid-based Medical Devices (Fillers) and Arthritis Therapies Product
75.4 %
91,266 74.1 % 114,797 75.4 % +25.78%
Hyaluronic Acid-based Medical Devices (Fillers) and Arthritis Therapies Merchandise
24.0 %
30,731 24.9 % 36,559 24.0 % +18.96%
Other
0.6 %
1,176 1.0 % 918 0.6 % -21.88%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
82.6 %
103,957 84.4 % 125,797 82.6 % +21.01%
Overseas
17.4 %
19,216 15.6 % 26,476 17.4 % +37.78%

Managers

Managers TitleAgeSince
Jin-Hwan Kim CEO
 Chief Executive Officer 58 -
Moon-Jung Lim CTO
 Chief Tech/Sci/R&D Officer 61 -
Sung-Tae Yoon BRD
 Director/Board Member 59 15-03-19

Members of the board

Members of the board TitleAgeSince
Sung-Tae Yoon BRD
 Director/Board Member 59 15-03-19
Joong-Sik Koh BRD
 Director/Board Member 69 -
Moon-Jung Lim CTO
 Chief Tech/Sci/R&D Officer 61 -
Jin-Hwan Kim CEO
 Chief Executive Officer 58 -
Seung-Bae Park BRD
 Director/Board Member 59 -
Kyung-Ho Hong BRD
 Director/Board Member 51 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 11,229,930 6,186,512 ( 55.09 %) 834,918 ( 7.435 %) 55.09 %

Shareholders

NameEquities%Valuation
HUONS GLOBAL CO., LTD.
36.08 %
4,051,873 36.08 % 99 M ₩
HUMEDIX CO., LTD.
7.573 %
850,405 7.573 % 21 M ₩
Yeon-sang Yoon
0.7787 %
87,444 0.7787 % 2 M ₩
Sung-Tae Yoon
0.3654 %
41,037 0.3654 % 1 M ₩
RAM Active Investments SA
0.2719 %
30,539 0.2719 % 745 743 ₩
Ji-hoon Lee
0.0935 %
10,500 0.0935 % 256 403 ₩
Jeong-seok Lee
0.0362 %
4,066 0.0362 % 99 289 ₩
Seung-jae Lee
0.0262 %
2,947 0.0262 % 71 964 ₩
Dimensional Fund Advisors Ltd.
0.0186 %
2,087 0.0186 % 50 963 ₩
DFA Australia Ltd.
0.0155 %
1,740 0.0155 % 42 490 ₩

Holdings

NameEquities%Valuation
HUMEDIX CO., LTD.
7.57%
 850,405 7.57% 20,766,346 $
ENSOL BIOSCIENCES INC.
5.08%
 550,055 5.08% 1,930,226 $

Company contact information

Humedix Co., Ltd.

17 Changeop-ro Sujeong-gu

13449, Anyang-si

+

http://www.humedix.com
address Humedix Co., Ltd.(A200670)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
33,950 KRW
Average target price
56,000 KRW
Spread / Average Target
+64.95%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
HUMEDIX CO., LTD. Stock Humedix Co., Ltd.
+0.59% 255M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.09% 694B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 593B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.34% 371B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 331B
ABBVIE INC. Stock AbbVie Inc.
+7.39% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 239B
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 209B
NOVARTIS AG Stock Novartis AG
+10.02% 209B
AMGEN INC. Stock Amgen Inc.
+8.49% 169B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A200670 Stock
  4. Company Humedix Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW